Intersect Capital’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$449K Buy
30,432
+1,064
+4% +$17.4K 0.14% 164
2022
Q1
$568K Buy
29,368
+10,424
+55% +$186K 0.11% 179
2021
Q4
$327K Buy
18,944
+4,505
+31% +$76.7K 0.06% 289
2021
Q3
$241K Buy
+14,439
New +$216K 0.04% 327

Other funds holding INVA

Intersect Capital's INVA Position: Q2 2022 in Review

Intersect Capital increased its Innoviva (INVA) stake by 3.6% in Q2 2022, buying an estimated $17.4K and bringing the position to 30,432 shares worth $449K. The position accounts for 0.14% of the portfolio, ranked #164.

Intersect Capital first reported a position in INVA in Q3 2021 and has held it in 4 quarters since. The position peaked at $568K in Q1 2022. 218 funds tracked by Wall St. Rank hold INVA as of Q2 2022.

  • Intersect Capital held 30,432 shares of Innoviva worth $449K as of Q2 2022.
  • Intersect Capital bought 1,064 Innoviva shares in Q2 2022, an estimated $17.4K.
  • Innoviva made up 0.14% of Intersect Capital's portfolio in Q2 2022, its #164 holding.
  • Intersect Capital first reported a position in Innoviva in Q3 2021 and has held it in 4 quarters since.
  • Intersect Capital's Innoviva position peaked at $568K in Q1 2022.
  • 218 funds tracked by Wall St. Rank held Innoviva as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.